Home › Malattie polmonari interstiziali › Kansas › Kansas City
Studi clinici su Malattie polmonari interstiziali a Kansas City, KS
13 studi su Malattie polmonari interstiziali cercano partecipanti presso sedi a Kansas City e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
In reclutamentoFase 3
- University of Kansas Medical Center, Kansas City
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
In reclutamentoFase 3
- University of Kansas Medical Center, Kansas City
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
In reclutamentoFase 3
- USA002, Kansas City
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
In reclutamentoFase 2
- University of Kansas Medical Center, Kansas City
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
In reclutamentoFase 2
- Clinical Research Site, Kansas City
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
In reclutamentoStudio osservazionale
- University of Kansas Medical Center, Kansas City
Platform Clinical Study for Conquering Scleroderma
In reclutamentoFase 2
- University of Kansas School of Medicine, Kansas City
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
In reclutamentoFase 2/3
- University of Kansas Medical Center, Kansas City
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
In reclutamentoFase 2
- The University of Kansas Medical Center Research Institute, Kansas City
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
In reclutamentoFase 3
- University of Kansas Medical Center, Kansas City
Interstitial Lung Disease Research Unit Biobank
In reclutamentoStudio osservazionale
- The University of Kansas Medical Center, Kansas City
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
In reclutamentoFase 1Volontari sani benvenuti
- University of Kansas Medical Center, Kansas City
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
In reclutamentoStudio osservazionale
- University of Kansas, Kansas City
Studi su Malattie polmonari interstiziali in altre città
- New York City, NY18 studi
- Philadelphia, PA16 studi
- Los Angeles, CA14 studi
- Charleston, SC13 studi
- Durham, NC13 studi
- Chicago, IL12 studi
- Houston, TX12 studi
- Aurora, CO11 studi
- Ann Arbor, MI11 studi
- Salt Lake City, UT9 studi
- Dallas, TX9 studi
- Boston, MA9 studi
Altri studi a Kansas City
- Malattie cardiovascolari14 studi
- Insufficienza cardiaca13 studi
- Obesità13 studi
- Fibrosi cistica13 studi
- Cancro al seno12 studi
- Cancro della vescica12 studi
- Leucemia mieloide acuta12 studi
- Cancro alla prostata12 studi
- Cancro del polmone non a piccole cellule11 studi
- Cancro ai polmoni11 studi
- BPCO9 studi
- Asma8 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.